SCHEMBL13764795

SCHEMBL13764795

C=CCOC(=O)C(N1C(=O)[C@H]([C@@H](C)O[Si](C)(C)C(C)(C)C)[C@H]1[C@@H](C)C(=O)OC(=O)C(C)(C)C)=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.33
ELANE P08246 1/20 0.32
MGLL Q99685 1/20 0.32
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6892042 1.00 FAAH (0.33) FAAHELANEMGLLPKMSMN1; SMN2
SCHEMBL3873801 1.00 FAAH (0.33) FAAHELANEMGLLPKMSMN1; SMN2
SCHEMBL6892231 0.91 ELANE (0.33) FAAHELANEMGLLPKMSMN1; SMN2
SCHEMBL13946276 0.91 ELANE (0.33) FAAHELANEMGLLPKMSMN1; SMN2
SCHEMBL9726095 0.91 ELANE (0.33) FAAHELANEMGLLPKMSMN1; SMN2
SCHEMBL3871262 0.88 ADRB2 (0.31) FAAHELANE
SCHEMBL13764796 0.88 ADRB2 (0.31) FAAHELANE
SCHEMBL13764797 0.87 ELANE (0.30) ELANE
SCHEMBL3871557 0.87 ELANE (0.30) ELANE
SCHEMBL9428362 0.87 FAAH (0.32) FAAHELANEMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563901-B2 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MEIJI SEIKA KAISHA, LTD. (JP) 2009-07-21 US disclosed
US-7524951-B2 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MEIJI SEIKA KAISHA, LTD. (JP) 2009-04-28 US disclosed
US-20090082571-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof SASAKI TOSHIRO 2009-03-26 US disclosed
US-20080167475-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof SASAKI TOSHIRO 2008-07-10 US disclosed
US-20080076917-A1 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof MEIJI SEIKA KAISHA, LTD. (JP) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167475-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MGAM, G6PD, COASY FAAH 4529/4885ELANE 2871/4885MGLL 2403/4885
US-20080076917-A1 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof MGAM, G6PD, COASY FAAH 4529/4885ELANE 2871/4885MGLL 2403/4885
US-20090082571-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MGAM, G6PD, COASY FAAH 4529/4885ELANE 2871/4885MGLL 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.